首页 > 最新文献

Surgery最新文献

英文 中文
Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases. 生长抑素受体正电子发射断层扫描在胰腺神经内分泌肿瘤淋巴结转移术前评估中的诊断价值。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-17 DOI: 10.1016/j.surg.2026.110136
Hallbera Gudmundsdottir, Fabricio J Hernandez-Delima, Bryan C McDowell, Patrick Starlinger, Cornelius A Thiels, Susanne G Warner, Thorvardur R Halfdanarson, Patrick J Navin, Annie T Packard, Sean P Cleary

Background: Regional lymph node involvement impacts prognosis for patients with pancreatic neuroendocrine tumors and may influence management decisions for small tumors. Conventional cross-sectional imaging modalities have low sensitivity in detecting regional lymph node metastases, but the diagnostic performance of somatostatin receptor positron emission tomography for this is unknown.

Methods: Patients with pancreatic neuroendocrine tumors who underwent preoperative gallium 68 DOTATATE positron emission tomography followed by resection with lymphadenectomy from 2017 to 2022 were reviewed. Preoperative gallium 68 DOTATATE positron emission tomography was retrospectively reviewed by radiologists. The presence of suspicious regional lymph nodes was correlated with pathologic reports to determine diagnostic accuracy.

Results: Among 130 patients who met inclusion criteria, DOTATATE positron emission tomography detected suspicious lymph nodes in 24%, whereas pathologic evaluation demonstrated lymph node involvement in 42%. Overall, sensitivity was 46% and specificity was 92%, with a positive predictive value of 81% and negative predictive value of 29%. Among patients with lymph node involvement confirmed on pathologic review, 92% of patients with true-positive results had a Krenning score of 4 compared with 59% of patients with false-negative results (P = .013), and 58% of patients with true-positive results had lymph nodes >1 cm on preoperative cross-sectional imaging compared with 8.7% of patients with false-negative results (P < .001).

Conclusion: Gallium 68 DOTATATE positron emission tomography has limited sensitivity but high specificity for preoperative diagnosis of regional pancreatic neuroendocrine tumor lymph node metastases. Detection rate improves with higher Krenning score and larger lymph node size. This study has important implications for preoperative planning, particularly for patients with small tumors who may be candidates for either observation or resection.

背景:局部淋巴结受累影响胰腺神经内分泌肿瘤患者的预后,并可能影响小肿瘤的治疗决策。传统的横断成像方式在检测区域淋巴结转移方面灵敏度较低,但生长抑素受体正电子发射断层扫描在这方面的诊断性能尚不清楚。方法:回顾性分析2017 - 2022年行术前镓68 DOTATATE正电子发射断层扫描并行淋巴结切除术的胰腺神经内分泌肿瘤患者。术前镓68 DOTATATE正电子发射断层扫描由放射科医生回顾性回顾。可疑区域淋巴结的存在与病理报告相关,以确定诊断的准确性。结果:在130例符合纳入标准的患者中,DOTATATE正电子发射断层扫描发现可疑淋巴结的占24%,而病理评估显示淋巴结受累的占42%。总体而言,敏感性为46%,特异性为92%,阳性预测值为81%,阴性预测值为29%。在病理检查证实淋巴结受累的患者中,92%的真阳性患者的Krenning评分为4分,而假阴性患者的这一比例为59% (P = 0.013); 58%的真阳性患者在术前横断面成像上淋巴结肿大1 cm,而假阴性患者的这一比例为8.7% (P < 0.001)。结论:镓68 DOTATATE正电子发射断层扫描对胰腺局部神经内分泌肿瘤淋巴结转移的术前诊断敏感性有限,但特异性较高。Krenning评分越高,淋巴结大小越大,检出率越高。这项研究对术前规划具有重要意义,特别是对于可能需要观察或切除的小肿瘤患者。
{"title":"Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases.","authors":"Hallbera Gudmundsdottir, Fabricio J Hernandez-Delima, Bryan C McDowell, Patrick Starlinger, Cornelius A Thiels, Susanne G Warner, Thorvardur R Halfdanarson, Patrick J Navin, Annie T Packard, Sean P Cleary","doi":"10.1016/j.surg.2026.110136","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110136","url":null,"abstract":"<p><strong>Background: </strong>Regional lymph node involvement impacts prognosis for patients with pancreatic neuroendocrine tumors and may influence management decisions for small tumors. Conventional cross-sectional imaging modalities have low sensitivity in detecting regional lymph node metastases, but the diagnostic performance of somatostatin receptor positron emission tomography for this is unknown.</p><p><strong>Methods: </strong>Patients with pancreatic neuroendocrine tumors who underwent preoperative gallium 68 DOTATATE positron emission tomography followed by resection with lymphadenectomy from 2017 to 2022 were reviewed. Preoperative gallium 68 DOTATATE positron emission tomography was retrospectively reviewed by radiologists. The presence of suspicious regional lymph nodes was correlated with pathologic reports to determine diagnostic accuracy.</p><p><strong>Results: </strong>Among 130 patients who met inclusion criteria, DOTATATE positron emission tomography detected suspicious lymph nodes in 24%, whereas pathologic evaluation demonstrated lymph node involvement in 42%. Overall, sensitivity was 46% and specificity was 92%, with a positive predictive value of 81% and negative predictive value of 29%. Among patients with lymph node involvement confirmed on pathologic review, 92% of patients with true-positive results had a Krenning score of 4 compared with 59% of patients with false-negative results (P = .013), and 58% of patients with true-positive results had lymph nodes >1 cm on preoperative cross-sectional imaging compared with 8.7% of patients with false-negative results (P < .001).</p><p><strong>Conclusion: </strong>Gallium 68 DOTATATE positron emission tomography has limited sensitivity but high specificity for preoperative diagnosis of regional pancreatic neuroendocrine tumor lymph node metastases. Detection rate improves with higher Krenning score and larger lymph node size. This study has important implications for preoperative planning, particularly for patients with small tumors who may be candidates for either observation or resection.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110136"},"PeriodicalIF":2.7,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147481715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baicalin attenuates burn wound progression by suppressing PANoptosis in the zone of stasis. 黄芩苷通过抑制瘀区PANoptosis来减缓烧伤创面进展。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-16 DOI: 10.1016/j.surg.2026.110148
Mengjing Xiao, Peirong Zhang, Xiaofang Zou, Hongming Yang

Background: The early progression of burn wounds poses a significant clinical challenge. Although inflammatory cell death is thought to be involved, the role of the newly discovered integrated cell death pathway PANoptosis in burn injuries has not yet been studied. Baicalin is a natural compound with anti-inflammatory properties and has therapeutic potential, but its impact on burn progression and PANoptosis is unknown.

Methods: A rat comb burn model was established. PANoptosis activation was assessed in the zone of stasis via Western blot, immunohistochemistry, and immunofluorescence for key markers (ZBP1, pMLKL, cleaved GSDMD, cleaved caspase-3, and ASC). In the intervention study, baicalin (100 mg/kg) or vehicle was administered for 7 days. PANoptosis markers, inflammatory cytokines (interleukin 1β, interleukin 6, interleukin 18, tumor necrosis factor α), myeloperoxidase activity, and histopathologic wound progression were evaluated.

Results: Burn injury induced time-dependent PANoptosis activation, characterized by coordinated upregulation of ZBP1, pMLKL, cleaved GSDMD, and cleaved caspase-3. Immunofluorescence confirmed PANoptosome assembly via ASC/cleaved caspase-3 colocalization. Baicalin treatment significantly suppressed all 3 PANoptosis executers, disrupted complex formation, reduced proinflammatory cytokines, and myeloperoxidase activity. Importantly, baicalin treatment significantly reduced the progression of burn wounds at day 7, as evidenced by diminished tissue necrosis and improved tissue architecture.

Conclusion: Our study identifies PANoptosis as a novel pathogenic mechanism contributing to burn wound progression. We further demonstrate that baicalin is an effective therapeutic agent that alleviates tissue damage possibly by inhibiting the PANoptosis pathway and its associated inflammatory cascade. These findings provide a new mechanistic understanding and highlight the therapeutic potential of baicalin for preventing burn wound deepening.

背景:烧伤创面的早期进展是一个重大的临床挑战。尽管炎性细胞死亡被认为参与其中,但新发现的综合细胞死亡途径PANoptosis在烧伤损伤中的作用尚未得到研究。黄芩苷是一种具有抗炎特性的天然化合物,具有治疗潜力,但其对烧伤进展和PANoptosis的影响尚不清楚。方法:建立大鼠梳子烧伤模型。通过Western blot、免疫组织化学和免疫荧光检测关键标志物(ZBP1、pMLKL、cleaved GSDMD、cleaved caspase-3和ASC),在停滞区评估PANoptosis激活情况。在干预研究中,黄芩苷(100 mg/kg)或对照物给药7天。评估PANoptosis标志物、炎症因子(白细胞介素1β、白细胞介素6、白细胞介素18、肿瘤坏死因子α)、髓过氧化物酶活性和组织病理学伤口进展。结果:烧伤诱导时间依赖性PANoptosis激活,其特征是ZBP1、pMLKL、cleaved GSDMD和cleaved caspase-3的协同上调。免疫荧光通过ASC/cleaved caspase-3共定位证实了PANoptosome的组装。黄芩苷处理显著抑制了所有3种PANoptosis执行因子,破坏了复合物的形成,降低了促炎细胞因子和髓过氧化物酶的活性。重要的是,黄芩苷治疗在第7天显著减少了烧伤创面的进展,这可以通过减少组织坏死和改善组织结构来证明。结论:我们的研究确定PANoptosis是一种促进烧伤创面进展的新的致病机制。我们进一步证明黄芩苷是一种有效的治疗药物,可能通过抑制PANoptosis途径及其相关的炎症级联来减轻组织损伤。这些发现为黄芩苷预防烧伤创面加深提供了新的机制认识,并突出了黄芩苷预防烧伤创面加深的治疗潜力。
{"title":"Baicalin attenuates burn wound progression by suppressing PANoptosis in the zone of stasis.","authors":"Mengjing Xiao, Peirong Zhang, Xiaofang Zou, Hongming Yang","doi":"10.1016/j.surg.2026.110148","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110148","url":null,"abstract":"<p><strong>Background: </strong>The early progression of burn wounds poses a significant clinical challenge. Although inflammatory cell death is thought to be involved, the role of the newly discovered integrated cell death pathway PANoptosis in burn injuries has not yet been studied. Baicalin is a natural compound with anti-inflammatory properties and has therapeutic potential, but its impact on burn progression and PANoptosis is unknown.</p><p><strong>Methods: </strong>A rat comb burn model was established. PANoptosis activation was assessed in the zone of stasis via Western blot, immunohistochemistry, and immunofluorescence for key markers (ZBP1, pMLKL, cleaved GSDMD, cleaved caspase-3, and ASC). In the intervention study, baicalin (100 mg/kg) or vehicle was administered for 7 days. PANoptosis markers, inflammatory cytokines (interleukin 1β, interleukin 6, interleukin 18, tumor necrosis factor α), myeloperoxidase activity, and histopathologic wound progression were evaluated.</p><p><strong>Results: </strong>Burn injury induced time-dependent PANoptosis activation, characterized by coordinated upregulation of ZBP1, pMLKL, cleaved GSDMD, and cleaved caspase-3. Immunofluorescence confirmed PANoptosome assembly via ASC/cleaved caspase-3 colocalization. Baicalin treatment significantly suppressed all 3 PANoptosis executers, disrupted complex formation, reduced proinflammatory cytokines, and myeloperoxidase activity. Importantly, baicalin treatment significantly reduced the progression of burn wounds at day 7, as evidenced by diminished tissue necrosis and improved tissue architecture.</p><p><strong>Conclusion: </strong>Our study identifies PANoptosis as a novel pathogenic mechanism contributing to burn wound progression. We further demonstrate that baicalin is an effective therapeutic agent that alleviates tissue damage possibly by inhibiting the PANoptosis pathway and its associated inflammatory cascade. These findings provide a new mechanistic understanding and highlight the therapeutic potential of baicalin for preventing burn wound deepening.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110148"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hiatal hernia repair: A single-institution experience and risk factors associated with early symptomatic recurrence. 裂孔疝修补:单一机构经验和早期症状复发相关的危险因素。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-16 DOI: 10.1016/j.surg.2026.110119
Patrick Strzempek, Pauline Aeschbacher, Elad Boaz, Brett Weiss, Sameh Hany Emile, Justin Dourado, Peter Rogers, Zoe Garoufalia, Samuel Szomstein, Emanuele Lo Menzo, Raul J Rosenthal

Background: Symptomatic recurrence after hiatal hernia repair poses several challenges, particularly as surgical options are limited. The use of mesh during hiatal hernia repair is controversial, as it is associated with long-term complications and a higher morbidity rate in case of redo surgery. Nevertheless, proponents of this technique argue that its use might reduce the risk of recurrence.

Methods: A retrospective analysis of hiatal hernia repair from 2011 to 2022 performed at our clinic was conducted. All hiatus defects were closed using barbed nonresorbable sutures without mesh. Univariate and multivariate logistic regression analyzed patient and operative characteristics for associations with early symptomatic recurrence in patients with ≥12-month follow-up. Early symptomatic recurrence was defined as redo surgery within 1-year post-primary repair. Kaplan-Meier estimator and log-rank test assessed cumulative recurrence rate.

Results: Of 1,226 patients with hiatal hernia repair, 74.1% (n = 908) were female, median age was 65 years (interquartile range 54, 72), and median body mass index was 28 kg/m2 (interquartile range 25, 33). Of repairs, 99.6% (n = 1,221) were laparoscopic and 14.4% (n = 177) were redo surgery, of which 43 had a previous mesh placement. Reoperation and mortality rates at 30 days were 2.6% (n = 32) and 0.1% (n = 1), respectively. Median follow-up was 12 months (interquartile range 1, 44). Symptomatic recurrences requiring reoperation were observed in 47 (3.8%) cases. In the univariate and multivariate logistic regression of 610 patients with ≥12-month follow-up, 2.5% (n = 15) experienced symptomatic recurrences. Open repair (odds ratio 5.37, P = .008) and redo surgery with previous mesh (odds ratio 7.69, P = .013) were independent risk factors for early recurrence with an area under the curve of 0.64. The cumulative recurrence rate at 1 year was significantly impacted by mesh use in previous repair (7.3%) compared with no mesh (2.9%) or no previous repair (1.4%) (P = .024).

Conclusion: Barbed nonresorbable suture closure during hiatal hernia repair is safe and effective in the short term. Open repair and redo surgery with previous mesh placement were associated with higher 1-year recurrence rates, underscoring the need for careful consideration in surgical planning.

背景:裂孔疝修补后的症状复发带来了一些挑战,特别是由于手术选择有限。在裂孔疝修补中使用补片是有争议的,因为它与长期并发症和重做手术的高发病率有关。然而,这项技术的支持者认为,它的使用可能会降低复发的风险。方法:回顾性分析2011年至2022年在我院进行的裂孔疝修补手术。所有裂孔缺损均采用无补片的倒钩不可吸收缝合线缝合。单因素和多因素logistic回归分析患者和手术特征与随访≥12个月患者早期症状复发的关系。早期症状复发定义为初次修复后1年内重做手术。Kaplan-Meier估计和log-rank检验评估累积复发率。结果:1226例裂孔疝修补患者中,女性占74.1% (n = 908),年龄中位数为65岁(四分位数范围54、72),体重指数中位数为28 kg/m2(四分位数范围25、33)。在修复中,99.6% (n = 1,221)为腹腔镜手术,14.4% (n = 177)为重做手术,其中43例先前放置过补片。30天的再手术率和死亡率分别为2.6% (n = 32)和0.1% (n = 1)。中位随访时间为12个月(四分位数间距1,44)。47例(3.8%)出现复发症状,需要再次手术。在随访≥12个月的610例患者的单因素和多因素logistic回归中,2.5% (n = 15)出现症状复发。开放式修复(优势比5.37,P = 0.008)和既往补片重做手术(优势比7.69,P = 0.013)是早期复发的独立危险因素,曲线下面积为0.64。与未使用补片(2.9%)或未使用补片(1.4%)相比,既往修复使用补片(7.3%)对1年累积复发率有显著影响(P = 0.024)。结论:在裂孔疝修补术中,有刺不可吸收缝合线短期内安全有效。先前放置补片的开放性修复和重做手术与较高的1年复发率相关,强调在手术计划中需要仔细考虑。
{"title":"Hiatal hernia repair: A single-institution experience and risk factors associated with early symptomatic recurrence.","authors":"Patrick Strzempek, Pauline Aeschbacher, Elad Boaz, Brett Weiss, Sameh Hany Emile, Justin Dourado, Peter Rogers, Zoe Garoufalia, Samuel Szomstein, Emanuele Lo Menzo, Raul J Rosenthal","doi":"10.1016/j.surg.2026.110119","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110119","url":null,"abstract":"<p><strong>Background: </strong>Symptomatic recurrence after hiatal hernia repair poses several challenges, particularly as surgical options are limited. The use of mesh during hiatal hernia repair is controversial, as it is associated with long-term complications and a higher morbidity rate in case of redo surgery. Nevertheless, proponents of this technique argue that its use might reduce the risk of recurrence.</p><p><strong>Methods: </strong>A retrospective analysis of hiatal hernia repair from 2011 to 2022 performed at our clinic was conducted. All hiatus defects were closed using barbed nonresorbable sutures without mesh. Univariate and multivariate logistic regression analyzed patient and operative characteristics for associations with early symptomatic recurrence in patients with ≥12-month follow-up. Early symptomatic recurrence was defined as redo surgery within 1-year post-primary repair. Kaplan-Meier estimator and log-rank test assessed cumulative recurrence rate.</p><p><strong>Results: </strong>Of 1,226 patients with hiatal hernia repair, 74.1% (n = 908) were female, median age was 65 years (interquartile range 54, 72), and median body mass index was 28 kg/m<sup>2</sup> (interquartile range 25, 33). Of repairs, 99.6% (n = 1,221) were laparoscopic and 14.4% (n = 177) were redo surgery, of which 43 had a previous mesh placement. Reoperation and mortality rates at 30 days were 2.6% (n = 32) and 0.1% (n = 1), respectively. Median follow-up was 12 months (interquartile range 1, 44). Symptomatic recurrences requiring reoperation were observed in 47 (3.8%) cases. In the univariate and multivariate logistic regression of 610 patients with ≥12-month follow-up, 2.5% (n = 15) experienced symptomatic recurrences. Open repair (odds ratio 5.37, P = .008) and redo surgery with previous mesh (odds ratio 7.69, P = .013) were independent risk factors for early recurrence with an area under the curve of 0.64. The cumulative recurrence rate at 1 year was significantly impacted by mesh use in previous repair (7.3%) compared with no mesh (2.9%) or no previous repair (1.4%) (P = .024).</p><p><strong>Conclusion: </strong>Barbed nonresorbable suture closure during hiatal hernia repair is safe and effective in the short term. Open repair and redo surgery with previous mesh placement were associated with higher 1-year recurrence rates, underscoring the need for careful consideration in surgical planning.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"193 ","pages":"110119"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147481692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simulation as a catalyst for surgical teamwork: Insights from a high-fidelity trauma training experience. 模拟作为外科团队合作的催化剂:来自高保真创伤训练经验的见解。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-16 DOI: 10.1016/j.surg.2026.110149
Galinos Barmparas, Aleeque Marselian, Falisha Kanji, Harshini Ravi, Bruce L Gewertz, Tara Cohen

Background: High-fidelity trauma simulation offers a unique opportunity to improve teamwork, communication, and crisis management in the operating room. Beyond technical skill acquisition, such simulations may foster interprofessional respect, self-reflection, and systems-level quality improvement awareness.

Methods: A post-simulation survey was completed by 90 participants following 2 high-fidelity trauma surgery scenarios conducted in a simulated operating room at an academic level 1 trauma center. Respondents included surgeons, surgical residents, anesthesiologists, circulating nurses, and scrub technicians from 8 institutions. Confidence in communication, teamwork, and role appreciation were measured using 5-point Likert scales and analyzed with paired-samples t tests and repeated-measures analysis of variance. Qualitative and quantitative items assessed perceived impact on communication practices and opportunities for process improvement.

Results: Confidence in communication improved from 3.67 ± 0.97 at baseline to 4.15 ± 0.81 after scenario 1 and 4.51 ± 0.61 after scenario 2 (P < .001 for all paired comparisons). Eighty-eight percent reported that participation in the simulation influenced how they would communicate in the operating room in the future, with the most common intended changes including enhanced name recognition (70%), closed-loop communication (70%), active listening (67%), and more frequent updates on patient status (47%). Participants emphasized the value of simulation as a quality-improvement tool, citing increased awareness of latent system issues, and the importance of interdisciplinary readiness. Perceived role importance increased most for circulating nurses (59%), anesthesiologists (49%), and scrub technicians (48%).

Conclusion: High-fidelity trauma simulation improved communication, strengthened teamwork, and promoted a culture of reflection and quality improvement across operating room disciplines. These findings support routine integration of immersive simulation into surgical and interprofessional training.

背景:高保真创伤模拟为提高手术室的团队合作、沟通和危机管理提供了独特的机会。除了获得技术技能之外,这样的模拟可以培养专业间的尊重、自我反思和系统级质量改进意识。方法:在某学术一级创伤中心的模拟手术室,对90名参与者进行2个高保真创伤手术场景的模拟后调查。受访者包括来自8家机构的外科医生、外科住院医师、麻醉师、循环护士和擦洗技师。使用5点李克特量表测量沟通、团队合作和角色欣赏方面的信心,并使用配对样本t检验和重复测量方差分析进行分析。定性和定量项目评估了对沟通实践和过程改进机会的感知影响。结果:沟通信心从基线时的3.67±0.97提高到场景1后的4.15±0.81和场景2后的4.51±0.61(所有配对比较P < 0.001)。88%的人报告说,参与模拟影响了他们未来在手术室的沟通方式,最常见的变化包括增强名字识别(70%)、闭环沟通(70%)、积极倾听(67%)和更频繁地更新患者状态(47%)。与会者强调了模拟作为一种质量改进工具的价值,理由是提高了对潜在系统问题的认识,以及跨学科准备的重要性。感知角色重要性增加最多的是循环护士(59%)、麻醉师(49%)和擦洗技师(48%)。结论:高保真创伤模拟改善了沟通,加强了团队合作,促进了手术室各学科间的反思文化和质量提高。这些发现支持将沉浸式模拟常规整合到外科和跨专业培训中。
{"title":"Simulation as a catalyst for surgical teamwork: Insights from a high-fidelity trauma training experience.","authors":"Galinos Barmparas, Aleeque Marselian, Falisha Kanji, Harshini Ravi, Bruce L Gewertz, Tara Cohen","doi":"10.1016/j.surg.2026.110149","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110149","url":null,"abstract":"<p><strong>Background: </strong>High-fidelity trauma simulation offers a unique opportunity to improve teamwork, communication, and crisis management in the operating room. Beyond technical skill acquisition, such simulations may foster interprofessional respect, self-reflection, and systems-level quality improvement awareness.</p><p><strong>Methods: </strong>A post-simulation survey was completed by 90 participants following 2 high-fidelity trauma surgery scenarios conducted in a simulated operating room at an academic level 1 trauma center. Respondents included surgeons, surgical residents, anesthesiologists, circulating nurses, and scrub technicians from 8 institutions. Confidence in communication, teamwork, and role appreciation were measured using 5-point Likert scales and analyzed with paired-samples t tests and repeated-measures analysis of variance. Qualitative and quantitative items assessed perceived impact on communication practices and opportunities for process improvement.</p><p><strong>Results: </strong>Confidence in communication improved from 3.67 ± 0.97 at baseline to 4.15 ± 0.81 after scenario 1 and 4.51 ± 0.61 after scenario 2 (P < .001 for all paired comparisons). Eighty-eight percent reported that participation in the simulation influenced how they would communicate in the operating room in the future, with the most common intended changes including enhanced name recognition (70%), closed-loop communication (70%), active listening (67%), and more frequent updates on patient status (47%). Participants emphasized the value of simulation as a quality-improvement tool, citing increased awareness of latent system issues, and the importance of interdisciplinary readiness. Perceived role importance increased most for circulating nurses (59%), anesthesiologists (49%), and scrub technicians (48%).</p><p><strong>Conclusion: </strong>High-fidelity trauma simulation improved communication, strengthened teamwork, and promoted a culture of reflection and quality improvement across operating room disciplines. These findings support routine integration of immersive simulation into surgical and interprofessional training.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110149"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do machine learning models add value in assessing operative stress? 机器学习模型在评估手术压力方面是否有价值?
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-16 DOI: 10.1016/j.surg.2026.110141
Michael A Jacobs, Paula K Shireman, Jonathan C Silverstein, Daniel E Hall
{"title":"Do machine learning models add value in assessing operative stress?","authors":"Michael A Jacobs, Paula K Shireman, Jonathan C Silverstein, Daniel E Hall","doi":"10.1016/j.surg.2026.110141","DOIUrl":"10.1016/j.surg.2026.110141","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110141"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomised controlled trials". 对“可切除胰腺癌的新辅助治疗与前期手术:更新的系统评价、个体患者数据荟萃分析和随机对照试验的试验序列分析”的评论。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-06 DOI: 10.1016/j.surg.2026.110124
Michael G House
{"title":"Commentary on \"Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomised controlled trials\".","authors":"Michael G House","doi":"10.1016/j.surg.2026.110124","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110124","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"110124"},"PeriodicalIF":2.7,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147373187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of corticosteroids on postoperative outcomes after hepatopancreatobiliary surgery 糖皮质激素对肝胆胰手术后预后的影响。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2025-12-02 DOI: 10.1016/j.surg.2025.109916
Abdullah Altaf MD, Selamawit Woldesenbet PhD, Kathleen Tong BA, Mujtaba Khalil MD, Miho Akabane MD, Zayed Rashid MD, Shahzaib Zindani MD, Azza Sarfraz MBBS, Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FSSO, FRACS (Hon)

Background

Phase 3 clinical trial data have suggested that perioperative administration of corticosteroids may improve postoperative outcomes by suppressing inflammatory and immune responses associated with surgery. We sought to investigate the real-world effectiveness of corticosteroid administration to improve postoperative outcomes among patients undergoing hepatopancreatobiliary surgery.

Methods

Patients who underwent hepatopancreatobiliary surgery (excluding simple cholecystectomy) between 2016 and 2024 were identified using the Epic Cosmos database. The primary exposure was the administration of a single shot of corticosteroids (methylprednisolone or hydrocortisone) on the day of surgery. Stabilized inverse probability of treatment weighting was used to examine the association between administration of corticosteroids and postoperative outcomes (ie, complications, length of stay, and 90-day mortality).

Results

Among 125,269 patients, a majority underwent pancreatic surgery (n = 65,663, 52.4%) for a nonmalignant indication (n = 79,145, 63.2%). Overall, 2.2% of patients (n = 2,782) were administered corticosteroids on the day of surgery. Patients who did versus did not receive corticosteroids were more likely to be younger (61.9 years [standard deviation ±14.7 years] vs 63.8 years [standard deviation ±14.8 years]), have a higher Charlson Comorbidity Index (>2) (79.5% vs 72.2%), and undergo hepatic surgery (42.7% vs 31.0%) via an open surgical approach (93.4% vs 86.5%) for a nonmalignant indication (72.9% vs 63.0%) (all P < .05). On inverse probability of treatment weighting analysis after adjusting for relevant clinicodemographic factors, administration of corticosteroids was associated with higher odds of postoperative complications (odds ratio: 2.16 [95% confidence interval: 1.93–2.42]), extended length of stay (>75th percentile) (odds ratio: 1.56 [95% confidence interval: 1.40–1.73]), and 90-day mortality (odds ratio: 1.26 [95% confidence interval: 1.11–1.41]) (all P < .001). On subgroup analyses, the administration of corticosteroids did not impact the incidence of bile leak among patients undergoing hepatobiliary surgery (odds ratio: 1.15 [95% confidence interval: 0.92–1.43]), nor did it affect the incidence of pancreatic fistula among patients undergoing pancreatic surgery (odds ratio: 1.11 [95% confidence interval: 0.83–1.47]) (both P > .05).

Conclusion

Based on real-world electronic health record data, administration of corticosteroids was not associated with improved outcomes after a hepatopancreatobiliary surgical procedure. Rather, use of same-day corticosteroids had a detrimental effect on postoperative outcomes, suggesting that steroids should not be routinely used in the perioperative hepatopancreatobiliary setting.
背景:3期临床试验数据表明围手术期给药皮质类固醇可以通过抑制手术相关的炎症和免疫反应来改善术后预后。我们试图调查使用皮质类固醇改善肝胆胰手术患者术后预后的实际有效性。方法:使用Epic Cosmos数据库对2016年至2024年间接受肝胆胰手术(不包括单纯胆囊切除术)的患者进行筛选。主要暴露是在手术当天单次注射皮质类固醇(甲基强的松或氢化可的松)。使用治疗加权的稳定逆概率来检查皮质类固醇给药与术后结果(即并发症、住院时间和90天死亡率)之间的关系。结果:在125,269例患者中,大多数患者因非恶性指征(n = 79,145, 63.2%)接受了胰腺手术(n = 65,663, 52.4%)。总体而言,2.2%的患者(n = 2782)在手术当天使用了皮质类固醇。接受糖皮质激素治疗的患者比未接受糖皮质激素治疗的患者更年轻(61.9岁[标准差±14.7岁]对63.8岁[标准差±14.8岁]),Charlson合病指数(>2)更高(79.5%对72.2%),并且由于非恶性指征(72.9%对63.0%),通过开放手术入路接受肝脏手术(42.7%对31.0%)(93.4%对86.5%)(均P < 0.05)。在调整相关临床人口统计学因素后的治疗加权逆概率分析中,皮质类固醇的使用与术后并发症的发生率(优势比:2.16[95%可信区间:1.93-2.42])、住院时间延长(75百分位)(优势比:1.56[95%可信区间:1.40-1.73])和90天死亡率(优势比:1.26[95%可信区间:1.11-1.41])相关(均P < 0.001)。在亚组分析中,皮质类固醇的使用没有影响肝胆手术患者的胆漏发生率(优势比:1.15[95%可信区间:0.92-1.43]),也没有影响胰手术患者的胰瘘发生率(优势比:1.11[95%可信区间:0.83-1.47])(P均为0.05)。结论:基于真实世界的电子健康记录数据,皮质类固醇的使用与肝胆胰外科手术后预后的改善无关。相反,当天使用皮质类固醇对术后结果有不利影响,提示类固醇不应常规用于围手术期肝胆胰治疗。
{"title":"Impact of corticosteroids on postoperative outcomes after hepatopancreatobiliary surgery","authors":"Abdullah Altaf MD,&nbsp;Selamawit Woldesenbet PhD,&nbsp;Kathleen Tong BA,&nbsp;Mujtaba Khalil MD,&nbsp;Miho Akabane MD,&nbsp;Zayed Rashid MD,&nbsp;Shahzaib Zindani MD,&nbsp;Azza Sarfraz MBBS,&nbsp;Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FSSO, FRACS (Hon)","doi":"10.1016/j.surg.2025.109916","DOIUrl":"10.1016/j.surg.2025.109916","url":null,"abstract":"<div><h3>Background</h3><div>Phase 3 clinical trial data have suggested that perioperative administration of corticosteroids may improve postoperative outcomes by suppressing inflammatory and immune responses associated with surgery. We sought to investigate the real-world effectiveness of corticosteroid administration to improve postoperative outcomes among patients undergoing hepatopancreatobiliary surgery.</div></div><div><h3>Methods</h3><div>Patients who underwent hepatopancreatobiliary surgery (excluding simple cholecystectomy) between 2016 and 2024 were identified using the Epic Cosmos database. The primary exposure was the administration of a single shot of corticosteroids (methylprednisolone or hydrocortisone) on the day of surgery. Stabilized inverse probability of treatment weighting was used to examine the association between administration of corticosteroids and postoperative outcomes (ie, complications, length of stay, and 90-day mortality).</div></div><div><h3>Results</h3><div>Among 125,269 patients, a majority underwent pancreatic surgery (<em>n</em> = 65,663, 52.4%) for a nonmalignant indication (<em>n</em> = 79,145, 63.2%). Overall, 2.2% of patients (<em>n</em> = 2,782) were administered corticosteroids on the day of surgery. Patients who did versus did not receive corticosteroids were more likely to be younger (61.9 years [standard deviation ±14.7 years] vs 63.8 years [standard deviation ±14.8 years]), have a higher Charlson Comorbidity Index (&gt;2) (79.5% vs 72.2%), and undergo hepatic surgery (42.7% vs 31.0%) via an open surgical approach (93.4% vs 86.5%) for a nonmalignant indication (72.9% vs 63.0%) (all <em>P</em> &lt; .05). On inverse probability of treatment weighting analysis after adjusting for relevant clinicodemographic factors, administration of corticosteroids was associated with higher odds of postoperative complications (odds ratio: 2.16 [95% confidence interval: 1.93–2.42]), extended length of stay (&gt;75th percentile) (odds ratio: 1.56 [95% confidence interval: 1.40–1.73]), and 90-day mortality (odds ratio: 1.26 [95% confidence interval: 1.11–1.41]) (all <em>P</em> &lt; .001). On subgroup analyses, the administration of corticosteroids did not impact the incidence of bile leak among patients undergoing hepatobiliary surgery (odds ratio: 1.15 [95% confidence interval: 0.92–1.43]), nor did it affect the incidence of pancreatic fistula among patients undergoing pancreatic surgery (odds ratio: 1.11 [95% confidence interval: 0.83–1.47]) (both <em>P</em> &gt; .05).</div></div><div><h3>Conclusion</h3><div>Based on real-world electronic health record data, administration of corticosteroids was not associated with improved outcomes after a hepatopancreatobiliary surgical procedure. Rather, use of same-day corticosteroids had a detrimental effect on postoperative outcomes, suggesting that steroids should not be routinely used in the perioperative hepatopancreatobiliary setting.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109916"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prospective cohort study of intraoperative parathyroid gland management by early and advanced career surgeons based on viability assessment by visual perception and indocyanine green (ICG) fluorescence imaging 早期和高级职业外科医生术中甲状旁腺管理的前瞻性队列研究基于视觉和吲胺绿(ICG)荧光成像的生存能力评估。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2025-12-03 DOI: 10.1016/j.surg.2025.109920
Nebojša Oravec MD, Rebecca Lahamm-Andraos MD, FACS, Emily A. Harris MD, FACS, Adrian M. Harvey MD, FRCSC, FACS, Samantha A. Wolfe MD, FRCSC, Caitlin T. Yeo MD, FRCSC

Background

Parathyroid gland identification and preservation during thyroidectomy has historically relied on experienced visual acumen. Indocyanine green fluorescence imaging has demonstrated improvement in parathyroid gland preservation, but it is unclear if the benefit is limited to less-experienced surgeons. The aim of this study was to identify how often discordant parathyroid viability assessments by surgeon visual perception versus indocyanine green fluorescence resulted in changes in management, stratified by surgeon years of experience.

Methods

Patients undergoing thyroid surgery by high-volume endocrine surgeons were recruited. Perception of parathyroid viability was documented before and after intravenous indocyanine green administration. In cases of discordant assessments, management was at the surgeon's discretion. Rates of discordance and change in management were stratified by surgeon experience—“early career” (<5 years independent practice) and “advanced career” (>15 years independent practice). Results were analyzed using the Pearson χ2 test. The primary outcome was the rate of change in management of the parathyroid on the basis of discordant assessments stratified by surgeon years of experience.

Results

Thirty-five patients were included and comprised 81 observations of parathyroid viability, 50 by early career surgeons and 31 by advanced-career surgeons. Early career surgeons had a discordance rate of 26.0% (n = 13/50) versus 19.3% (n = 6/31) for advanced career surgeons (χ2 = 0.17329, P = .6722). Of the 19 discordant observations, 13 (68.4%) resulted in changes in management (early career = 10/13 = 76.9%; advanced career = 3/6 = 50.0%; χ2 = 1.3772, P = .3093).

Conclusion

These results suggest that indocyanine green fluorescence imaging is a useful adjunct to visual perception, regardless of the surgeon's years of experience.
背景:甲状腺切除术中甲状旁腺的识别和保存历来依赖于经验丰富的视力。靛绿色荧光成像显示了甲状旁腺保存的改善,但尚不清楚这种益处是否仅限于经验不足的外科医生。本研究的目的是确定外科医生的视觉感知与吲啶绿荧光的甲状旁腺活力评估不一致导致管理改变的频率,并根据外科医生的经验分层。方法:招募大容量内分泌外科医生行甲状腺手术的患者。在静脉注射吲哚菁绿前后记录甲状旁腺活力的感觉。在评估不一致的情况下,治疗由外科医生自行决定。不一致率和管理改变率按外科医生经验分层-“早期职业”(15年独立执业)。采用Pearson χ2检验对结果进行分析。主要结局是甲状旁腺治疗的变化率,这是基于外科医生多年经验分层的不一致评估。结果:纳入35例患者,其中甲状旁腺功能观察81例,早期职业外科医生50例,高级职业外科医生31例。早期职业外科医生的不一致性率为26.0% (n = 13/50),而高级职业外科医生的不一致性率为19.3% (n = 6/31) (χ2 = 0.17329, P = 0.6722)。19例不一致观察中,13例(68.4%)导致管理发生变化(早期职业= 10/13 = 76.9%;晚期职业= 3/6 = 50.0%;χ2 = 1.3772, P = 0.3093)。结论:这些结果表明吲哚菁绿荧光成像是一种有用的视觉感知辅助手段,与外科医生的经验无关。
{"title":"A prospective cohort study of intraoperative parathyroid gland management by early and advanced career surgeons based on viability assessment by visual perception and indocyanine green (ICG) fluorescence imaging","authors":"Nebojša Oravec MD,&nbsp;Rebecca Lahamm-Andraos MD, FACS,&nbsp;Emily A. Harris MD, FACS,&nbsp;Adrian M. Harvey MD, FRCSC, FACS,&nbsp;Samantha A. Wolfe MD, FRCSC,&nbsp;Caitlin T. Yeo MD, FRCSC","doi":"10.1016/j.surg.2025.109920","DOIUrl":"10.1016/j.surg.2025.109920","url":null,"abstract":"<div><h3>Background</h3><div>Parathyroid gland identification and preservation during thyroidectomy has historically relied on experienced visual acumen. Indocyanine green fluorescence imaging has demonstrated improvement in parathyroid gland preservation, but it is unclear if the benefit is limited to less-experienced surgeons. The aim of this study was to identify how often discordant parathyroid viability assessments by surgeon visual perception versus indocyanine green fluorescence resulted in changes in management, stratified by surgeon years of experience.</div></div><div><h3>Methods</h3><div>Patients undergoing thyroid surgery by high-volume endocrine surgeons were recruited. Perception of parathyroid viability was documented before and after intravenous indocyanine green administration. In cases of discordant assessments, management was at the surgeon's discretion. Rates of discordance and change in management were stratified by surgeon experience—“early career” (&lt;5 years independent practice) and “advanced career” (&gt;15 years independent practice). Results were analyzed using the Pearson χ<sup>2</sup> test. The primary outcome was the rate of change in management of the parathyroid on the basis of discordant assessments stratified by surgeon years of experience.</div></div><div><h3>Results</h3><div>Thirty-five patients were included and comprised 81 observations of parathyroid viability, 50 by early career surgeons and 31 by advanced-career surgeons. Early career surgeons had a discordance rate of 26.0% (<em>n</em> = 13/50) versus 19.3% (<em>n</em> = 6/31) for advanced career surgeons (χ<sup>2</sup> = 0.17329, <em>P</em> = .6722). Of the 19 discordant observations, 13 (68.4%) resulted in changes in management (early career = 10/13 = 76.9%; advanced career = 3/6 = 50.0%; χ<sup>2</sup> = 1.3772, <em>P</em> = .3093).</div></div><div><h3>Conclusion</h3><div>These results suggest that indocyanine green fluorescence imaging is a useful adjunct to visual perception, regardless of the surgeon's years of experience.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109920"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between state gun policies and firearm-related deaths in the United States: A mixed-effects analysis from 2003 to 2022 美国各州枪支政策与枪支相关死亡之间的关系:2003年至2022年的混合效应分析。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2026-01-20 DOI: 10.1016/j.surg.2025.109911
Melissa A. Kendall MD, Emily A. Grimsley MD, Rachel L. Wolansky MD, Joseph Sujka MD, Paul C. Kuo MD, MS, MBA

Background

Firearm-related deaths are prevalent in the United States, with the second greatest total recorded in 2022. Data associating handgun policies with firearm-related crude death rates by all intentions and crude suicide rates remain inconclusive. We aimed to identify associations between handgun policies and crude death rates and crude suicide rates over time.

Methods

We queried the Centers for Disease Control and Prevention database for adult crude death rates and crude suicide rates in the United States and the Research and Development Firearm Database to identify state-specific handgun policies. We analyzed data from 2003 to 2022 using 2 mixed-effects models: crude death rates and crude suicide rates. Linear and quadratic interaction terms captured changes in policy effectiveness over time. Robust standard errors accounted for heteroscedasticity, improving estimate reliability.

Results

Safety training requirements reduced crude death rates by 29.0% (P < .01), followed by possession restrictions (12.2%; P < .01), registration requirements (8.9%; P < .05), and tracing requirements (6.1%; P < .05). Permit requirements reduced crude suicide rates by 15.9% (P < .05), followed by extreme risk protection orders (6.7%; P < .001), untraceable firearms restrictions 5.9%; P < .05), tracing requirements (4.3%; P < .05), and trafficking policies (4.2%; P < .05). Preemption of local policies increased crude suicide rates by 9.8% (P < .01). The effect of tracing requirements increased from 2003–2022 for both crude death rates (6.1% to 30.6%; P < .01) and crude suicide rates (4.3% to 22.5%; P < .05). The effect of preemption of select local policies initially weakened from 2003–2012, (+12.2% to +9.7%), then strengthened to +15.3% in 2022 (P < .01).

Conclusion

Safety training, possession requirements, handgun registration, and tracing policies are associated with lower crude death rates. Permit requirements, extreme risk protection orders, untraceable firearm restrictions, tracing, and trafficking policies are associated with lower crude suicide rates. Implementation of these policies nationwide may reduce crude death rates and crude suicide rates.
背景:与枪支有关的死亡在美国很普遍,在2022年记录的总数中排名第二。将手枪政策与枪支相关的各种意图的粗死亡率和粗自杀率联系起来的数据仍然没有定论。我们的目的是确定手枪政策与粗死亡率和粗自杀率之间的关系。方法:我们查询了美国疾病控制与预防中心的成人粗死亡率和粗自杀率数据库以及研究与发展枪支数据库,以确定各州具体的手枪政策。我们使用两种混合效应模型分析了2003年至2022年的数据:粗死亡率和粗自杀率。线性和二次交互项捕获了政策有效性随时间的变化。稳健的标准误差解释了异方差,提高了估计的可靠性。结果:安全培训要求使粗死亡率降低29.0% (P < 0.01),其次是持有限制(12.2%,P < 0.01)、登记要求(8.9%,P < 0.05)和追踪要求(6.1%,P < 0.05)。许可证要求使粗自杀率降低了15.9% (P < 0.05),其次是极端风险保护令(6.7%,P < 0.001),不可追踪枪支限制5.9%;P < 0.05)、追踪要求(4.3%,P < 0.05)和贩运政策(4.2%,P < 0.05)。对地方政策的预防使粗自杀率增加了9.8% (P < 0.01)。从2003年到2022年,追踪要求对粗死亡率(6.1%至30.6%,P < 0.01)和粗自杀率(4.3%至22.5%,P < 0.05)的影响都有所增加。2003-2012年,部分地方政策的优先选择效应开始减弱(+12.2% ~ +9.7%),到2022年,优先选择效应增强至+15.3% (P < 0.01)。结论:安全培训、持有要求、手枪登记和追踪政策与较低的粗死亡率有关。许可证要求、极端风险保护令、无法追踪的枪支限制、追踪和贩运政策与较低的粗自杀率有关。在全国范围内实施这些政策可能会降低粗死亡率和粗自杀率。
{"title":"Associations between state gun policies and firearm-related deaths in the United States: A mixed-effects analysis from 2003 to 2022","authors":"Melissa A. Kendall MD,&nbsp;Emily A. Grimsley MD,&nbsp;Rachel L. Wolansky MD,&nbsp;Joseph Sujka MD,&nbsp;Paul C. Kuo MD, MS, MBA","doi":"10.1016/j.surg.2025.109911","DOIUrl":"10.1016/j.surg.2025.109911","url":null,"abstract":"<div><h3>Background</h3><div>Firearm-related deaths are prevalent in the United States, with the second greatest total recorded in 2022. Data associating handgun policies with firearm-related crude death rates by all intentions and crude suicide rates remain inconclusive. We aimed to identify associations between handgun policies and crude death rates and crude suicide rates over time.</div></div><div><h3>Methods</h3><div>We queried the Centers for Disease Control and Prevention database for adult crude death rates and crude suicide rates in the United States and the Research and Development Firearm Database to identify state-specific handgun policies. We analyzed data from 2003 to 2022 using 2 mixed-effects models: crude death rates and crude suicide rates. Linear and quadratic interaction terms captured changes in policy effectiveness over time. Robust standard errors accounted for heteroscedasticity, improving estimate reliability.</div></div><div><h3>Results</h3><div>Safety training requirements reduced crude death rates by 29.0% (<em>P</em> &lt; .01), followed by possession restrictions (12.2%; <em>P</em> &lt; .01), registration requirements (8.9%; <em>P</em> &lt; .05), and tracing requirements (6.1%; <em>P</em> &lt; .05). Permit requirements reduced crude suicide rates by 15.9% (<em>P</em> &lt; .05), followed by extreme risk protection orders (6.7%; <em>P</em> &lt; .001), untraceable firearms restrictions 5.9%; <em>P</em> &lt; .05), tracing requirements (4.3%; <em>P</em> &lt; .05), and trafficking policies (4.2%; <em>P</em> &lt; .05). Preemption of local policies increased crude suicide rates by 9.8% (<em>P</em> &lt; .01). The effect of tracing requirements increased from 2003–2022 for both crude death rates (6.1% to 30.6%; <em>P</em> &lt; .01) and crude suicide rates (4.3% to 22.5%; <em>P</em> &lt; .05). The effect of preemption of select local policies initially weakened from 2003–2012, (+12.2% to +9.7%), then strengthened to +15.3% in 2022 (<em>P</em> &lt; .01).</div></div><div><h3>Conclusion</h3><div>Safety training, possession requirements, handgun registration, and tracing policies are associated with lower crude death rates. Permit requirements, extreme risk protection orders, untraceable firearm restrictions, tracing, and trafficking policies are associated with lower crude suicide rates. Implementation of these policies nationwide may reduce crude death rates and crude suicide rates.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109911"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axillary staging outcomes in women undergoing mastectomy for ductal carcinoma in situ in the era of gene expression assays 在基因表达测定时代,接受乳腺导管原位癌切除术的妇女腋窝分期结果。
IF 2.7 2区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2025-12-06 DOI: 10.1016/j.surg.2025.109909
Anna Levine DO , Hayden Wood BS , Ibukunoluwa Omole BA , Amie M. Hop MD , G. Paul Wright MD , Jessica L. Thompson MD

Background

Approximately 20% of women diagnosed with ductal carcinoma in situ on core biopsy will be upstaged to invasive disease on final pathology. Sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ is the current standard of care. However, the underlying invasive cancer is frequently of low grade with favorable biology, bringing into question the necessity of sentinel lymph node biopsy to help guide clinical treatment recommendations. The primary study objective was to determine how often sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ alters adjuvant therapy recommendations.

Methods

A single-institution cancer registry retrospectively identified women treated with mastectomy for a preoperative diagnosis of ductal carcinoma in situ between November 2017 and November 2023, excluding those with a previous history of ipsilateral breast cancer. The impact of pathologic nodal status on adjuvant treatment was evaluated.

Results

The study population included 175 patients with a total of 38 invasive cancers identified. Of those with pT1 malignancies, 3 had a positive sentinel node. One patient was recommended for additional adjuvant treatment, in the form of radiation therapy, as a result of axillary staging. No patients were recommended for chemotherapy based solely on sentinel lymph node biopsy results.

Conclusion

Despite current recommendations to perform sentinel lymph node biopsy in ductal carcinoma in situ treated with mastectomy in the event invasive cancer is identified on final pathology, our outcomes suggest nodal status has limited impact on adjuvant therapy offerings. These findings indicate that sentinel lymph node biopsy may not be requisite for every patient undergoing mastectomy for ductal carcinoma in situ.
背景:大约20%的核心活检诊断为导管原位癌的女性在最终病理上被诊断为浸润性疾病。前哨淋巴结活检在乳房切除术时导管原位癌是目前的标准护理。然而,潜在的浸润性癌症往往是低级别的,具有良好的生物学特性,这就对前哨淋巴结活检的必要性提出了质疑,以帮助指导临床治疗建议。主要研究目的是确定乳腺导管原位癌切除术时前哨淋巴结活检的频率如何改变辅助治疗建议。方法:对2017年11月至2023年11月期间接受乳腺切除术术前诊断为导管原位癌的女性进行回顾性癌症登记,不包括既往有同侧乳腺癌病史的女性。评估病理结节状态对辅助治疗的影响。结果:研究人群包括175名患者,共确定了38种侵袭性癌症。在pT1恶性肿瘤患者中,3例前哨淋巴结阳性。由于腋窝分期,一名患者被推荐进行额外的辅助治疗,以放射治疗的形式。没有患者仅根据前哨淋巴结活检结果推荐化疗。结论:尽管目前的建议是,如果最终病理发现浸润性癌症,则对经乳腺切除术治疗的导管原位癌进行前哨淋巴结活检,但我们的研究结果表明,淋巴结状态对辅助治疗的影响有限。这些研究结果表明,前哨淋巴结活检可能不是每一个接受乳腺导管原位癌切除术的患者所必需的。
{"title":"Axillary staging outcomes in women undergoing mastectomy for ductal carcinoma in situ in the era of gene expression assays","authors":"Anna Levine DO ,&nbsp;Hayden Wood BS ,&nbsp;Ibukunoluwa Omole BA ,&nbsp;Amie M. Hop MD ,&nbsp;G. Paul Wright MD ,&nbsp;Jessica L. Thompson MD","doi":"10.1016/j.surg.2025.109909","DOIUrl":"10.1016/j.surg.2025.109909","url":null,"abstract":"<div><h3>Background</h3><div>Approximately 20% of women diagnosed with ductal carcinoma in situ on core biopsy will be upstaged to invasive disease on final pathology. Sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ is the current standard of care. However, the underlying invasive cancer is frequently of low grade with favorable biology, bringing into question the necessity of sentinel lymph node biopsy to help guide clinical treatment recommendations. The primary study objective was to determine how often sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ alters adjuvant therapy recommendations.</div></div><div><h3>Methods</h3><div>A single-institution cancer registry retrospectively identified women treated with mastectomy for a preoperative diagnosis of ductal carcinoma in situ between November 2017 and November 2023, excluding those with a previous history of ipsilateral breast cancer. The impact of pathologic nodal status on adjuvant treatment was evaluated.</div></div><div><h3>Results</h3><div>The study population included 175 patients with a total of 38 invasive cancers identified. Of those with pT1 malignancies, 3 had a positive sentinel node. One patient was recommended for additional adjuvant treatment, in the form of radiation therapy, as a result of axillary staging. No patients were recommended for chemotherapy based solely on sentinel lymph node biopsy results.</div></div><div><h3>Conclusion</h3><div>Despite current recommendations to perform sentinel lymph node biopsy in ductal carcinoma in situ treated with mastectomy in the event invasive cancer is identified on final pathology, our outcomes suggest nodal status has limited impact on adjuvant therapy offerings. These findings indicate that sentinel lymph node biopsy may not be requisite for every patient undergoing mastectomy for ductal carcinoma in situ.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109909"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1